Literature DB >> 27720439

Etiology of Heart Failure and Outcomes in Patients Hospitalized for Acute Decompensated Heart Failure With Preserved or Reduced Ejection Fraction.

Katsuya Kajimoto1, Yuichiro Minami2, Naoki Sato3, Hiroshi Kasanuki4.   

Abstract

In the setting of acute decompensated heart failure (HF), relations among the etiology of HF, left ventricular systolic function, and outcomes are unclear. The aim of this study was to investigate the association of HF etiology with outcomes in patients with acute decompensated HF with a preserved or reduced ejection fraction (EF). Of the 4,842 patients enrolled in the Acute Decompensated Heart Failure Syndromes registry, 3,810 patients (1,601 with a preserved EF and 2,209 with a reduced EF) who had a hypertensive, ischemic, valvular, or idiopathic dilated etiology of HF were investigated to assess the association of etiology with a composite end point (all-cause mortality and readmission for HF). The median follow-up period after admission was 502 (381 to 759) days. The composite end point was reached in 44.6% and 41.7% of the preserved and reduced EF groups, respectively. After adjustment for multiple co-morbidities, the risk of the composite end point was comparable among hypertensive, ischemic, and valvular etiologies in the preserved EF group. In contrast, in the reduced EF group, ischemic etiology was associated with a tendency toward greater risk of the composite end point than hypertensive etiology (but this difference was not significant), whereas valvular etiology was associated with a significantly greater risk of the composite end point relative to hypertensive or idiopathic dilated etiology. In conclusion, this study demonstrated that taking the etiology of HF into account may help to reduce the heterogeneity of acute decompensated HF and assist in identifying patients at risk of adverse outcomes, especially among patients with reduced EF. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27720439     DOI: 10.1016/j.amjcard.2016.08.080

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Recurrent Acute Decompensated Heart Failure Admissions for Patients With Reduced Versus Preserved Ejection Fraction (from the Atherosclerosis Risk in Communities Study).

Authors:  Melissa C Caughey; Carla A Sueta; Sally C Stearns; Amil M Shah; Wayne D Rosamond; Patricia P Chang
Journal:  Am J Cardiol       Date:  2018-03-28       Impact factor: 2.778

2.  Multimorbidity, guideline-directed medical therapies, and associated outcomes among hospitalized heart failure patients.

Authors:  Shinsuke Takeuchi; Takashi Kohno; Ayumi Goda; Yasuyuki Shiraishi; Masataka Kawana; Mike Saji; Yuji Nagatomo; Yosuke Nishihata; Makoto Takei; Shintaro Nakano; Kyoko Soejima; Shun Kohsaka; Tsutomu Yoshikawa
Journal:  ESC Heart Fail       Date:  2022-05-13

3.  Clinical findings and prognosis of patients hospitalized for acute decompensated heart failure: Analysis of the influence of Chagas etiology and ventricular function.

Authors:  Caíque Bueno Terhoch; Henry Fukuda Moreira; Silvia Moreira Ayub-Ferreira; Germano Emilio Conceição-Souza; Vera Maria Cury Salemi; Paulo Roberto Chizzola; Mucio Tavares Oliveira; Silvia Helena Gelas Lage; Edimar Alcides Bocchi; Victor Sarli Issa
Journal:  PLoS Negl Trop Dis       Date:  2018-02-12

4.  Association between comorbid cardiomyopathy and composite endpoints of patients with congestive heart failure in the intensive care unit: a retrospective cohort study.

Authors:  Lifeng Liang; Jiayi Sun; Lizhu Chen; Zejian Li; Wenjuan Zhang
Journal:  J Thorac Dis       Date:  2022-07       Impact factor: 3.005

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.